CYTOSOLIC 5'-NUCLEOTIDASE NUCLEOSIDE PHOSPHOTRANSFERASE - A NUCLEOSIDE ANALOG ACTIVATING ENZYME

被引:12
|
作者
TURRIANI, M
PESI, R
NARDONE, A
TURCHI, G
SGARRELLA, F
IPATA, PL
TOZZI, MG
机构
[1] EUROPEAN CTR VALIDAT ALTERNAT METHODS,I-21020 ISPRA,ITALY
[2] CNR,IST MUTAGENESI & DIFFERENZIAMENTO,I-56100 PISA,ITALY
[3] UNIV SASSARI,FAC FARM,IST CHIM BIOL,I-07100 SASSARI,ITALY
来源
JOURNAL OF BIOCHEMICAL TOXICOLOGY | 1994年 / 9卷 / 01期
关键词
5'-NUCLEOTIDASE; NUCLEOSIDE ANALOGS; PRODRUGS ACTIVATION;
D O I
10.1002/jbt.2570090108
中图分类号
R99 [毒物学(毒理学)];
学科分类号
100405 ;
摘要
Nucleoside phosphotransferase acting on inosine and deoxyinosine has been partially purified from cultured Chinese hamster lung fibroblasts (V79). The activity is associated with a cytosolic 5'-nucleotidase acting on IMP and deoxyIMP. The transfer of the phosphate group from IMP to inosine catalyzed by this enzyme was activated by ATP and 2,3-bisphosphoglycerate. Inosine, deoxyinosine, guanosine, deoxyguanosine, and the nucleoside analogs 2',3'-dideoxyinosine and 8-azaguanosine are substrates, while adenosine and deoxyadenosine are not. IMP, deoxyIMP, GMP, and deoxyGMP are the best phosphate donors. The cytosolic 5'-nucleotidase/phosphotransferase substrate, 8-azaguanosine, was found to be very toxic for cultured fibroblasts (LD50 = 0.32 muM). Mutants resistant to either 8-azaguanosine and the correspondent base 8-azaguanine were isolated and characterized. Our results indicated that the 8-azaguanosine-resistant cells were lacking both cytosolic 5'-nucleotidase and hypoxanthine-guanine phosphoribosyltransferase, while 8-azaguanine resistant cells were lacking only the latter enzyme. Despite this observation, both mutants displayed 8-azaguanosine resistance, thus indicating that cytosolic 5'-nucleotidase is not essential for the activation of this nucleoside analog.
引用
收藏
页码:51 / 57
页数:7
相关论文
共 50 条
  • [31] PURIFICATION AND PROPERTIES OF A NUCLEOSIDE PHOSPHOTRANSFERASE FROM CARROT
    BRUNNGRA.EF
    CHARGAFF, E
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1967, 242 (20) : 4834 - &
  • [32] Engineering of nucleoside kinases to improve the activation of nucleoside analog prodrugs
    Konrad, M.
    Ort, S.
    Monnerjahn, C.
    Lavie, A.
    FEBS JOURNAL, 2006, 273 : 50 - 50
  • [33] The purine analog fludarabine acts as a cytosolic 5′-nucleotidase II inhibitor
    Cividini, F.
    Pesi, R.
    Chaloin, L.
    Allegrini, S.
    Camici, M.
    Cros-Perrial, E.
    Dumontet, C.
    Jordheim, L. P.
    Tozzi, M. G.
    BIOCHEMICAL PHARMACOLOGY, 2015, 94 (02) : 63 - 68
  • [34] A NEW KINETIC METHOD FOR ASSAYING SERUM 5'-NUCLEOTIDASE USING NUCLEOSIDE OXIDASE
    ISONO, Y
    TSUJIMOTO, H
    HOSHINO, M
    AGRICULTURAL AND BIOLOGICAL CHEMISTRY, 1989, 53 (10): : 2667 - 2671
  • [35] Enforced expression of cytosolic 5′-nucleotidase I confers resistance to nucleoside analogues in vitro but systemic chemotherapy toxicity precludes in vivo selection
    Gray, T
    Morrey, EL
    Gangadharan, B
    Sumter, TF
    Spychala, J
    Archer, DR
    Spencer, HT
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2006, 58 (01) : 117 - 128
  • [36] NUCLEOSIDE ANALOG TOXICITY AND MITOCHONDRIA
    LAU, D
    MOSTOWSKI, H
    HOOFNAGLE, JH
    SALLIE, R
    HEPATOLOGY, 1994, 20 (04) : A189 - A189
  • [37] NUCLEOSIDE AND NUCLEOBASE ANALOG MUTAGENS
    NEGISHI, K
    BESSHO, T
    HAYATSU, H
    MUTATION RESEARCH-REVIEWS IN GENETIC TOXICOLOGY, 1994, 318 (03): : 227 - 238
  • [38] STUDIES ON DECOYININE NUCLEOSIDE ANALOG
    BLOCH, A
    NICHOL, CA
    FEDERATION PROCEEDINGS, 1964, 23 (2P1) : 324 - &
  • [40] PYRIMIDINE NUCLEOSIDE MONOPHOSPHATE KINASE HYPERACTIVITY IN HEREDITARY PYRIMIDINE 5'-NUCLEOTIDASE DEFICIENCY
    LACHANT, NA
    TANAKA, KR
    CLINICAL RESEARCH, 1986, 34 (02): : A719 - A719